Association of Sexual Dysfunction With Lower Urinary Tract Symptoms of BPH and BPH Medical Therapies: Results From the BPH Registry

Urology

Volumn 73, Issue 3, 2009, Pages 562-566

  Rosen, Raymond C ^a   Wei, John T ^b   Althof, Stanley E ^c,d   Seftel, Allen D ^e   Miner, Martin ^f   Perelman, Michael A ^g  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Center for Marital and Sexual Health of South Florida   (United States)

^e UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^f BROWN UNIVERSITY   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TERAZOSIN;

ADULT; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; EJACULATION DISORDER; ERECTILE DYSFUNCTION; ETHNICITY; HUMAN; HYPERTENSION; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SEXUAL DYSFUNCTION;

AGED; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PROSTATISM; REGISTRIES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 60549083255     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.05.034     Document Type: Article

References (23)

1. Rosen R., Altwein J., Boyle P., et al. Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7). Eur Urol 44 (2003) 637-649
2. Blanker M.H., Bohnen A.M., Groeneveld F.P., et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: A community-based study. J Am Geriatr Soc 49 (2001) 436-442
3. McVary K.T. Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur Urol 47 (2005) 838-845
4. Rosen R., Carson C., and Giuliano F. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Eur Urol 47 (2005) 824-837
5. NIH Consensus Development Panel on Impotence. NIH Consensus Conference. Impotence. JAMA 270 (1993) 83-90
6. Arai Y., Aoki Y., Okubo K., et al. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: A prospective study. J Urol 164 (2000) 1206-1211
7. Thompson I.M., Tangen C.M., Goodman P.J., et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA 294 (2005) 2996-3002
8. Lindau S.T., Schumm L.P., Laumann E.O., et al. A study of sexuality and health among older adults in the United States. N Engl J Med 357 (2007) 762-774
9. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia; 2003. Chapter 1: Diagnosis and treatment recommendations. J Urol 170 (2003) 530-547
10. Carbone Jr. D.J., and Hodges S. Medical therapy for benign prostatic hyperplasia: Sexual dysfunction and impact on quality of life. Int J Impot Res 15 (2003) 299-306
11. Schulman C. Impact of treatment of BPH on sexuality. Prostate Cancer Prostatic Dis 4 (2001) S12-S16
12. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia; 2003. Chapter 3: Results of the treatment outcomes analyses (2003), American Urological Association, Linthincum, MD
13. Roehrborn C.G., Van Kerrebroeck P., and Nordling J. Safety and efficacy of alfuzosin, 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: A pooled analysis of three double-blind, placebo-controlled studies. BJU Int 92 (2003) 257-261
14. Roehrborn C.G., Nuckolls J.G., Wei J.T., et al. The Benign Prostatic Hyperplasia Registry and Patient survey: Study design, methods and patient baseline characteristics. BJU Int 100 (2007) 813-819
15. Barry M.J., Fowler Jr. F.J., O'Leary M.P., et al., Measurement Committee of the American Urological Association. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 148 (1992) 1549-1557 1564
16. Rosen R.C., Cappelleri J.C., Smith M.D., et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11 (1999) 319-326
17. Rosen R., Catania J., Pollack L., et al. Male Sexual Health Questionnaire (MSHQ): Scale development and psychometric validation. Urology 64 (2004) 777-782
18. Rosen R.C., Catania J.A., Althof S.E., et al. Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction. Urology 69 (2007) 805-809
19. Vallancien G., Emberton M., Harving N., et al. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol 169 (2003) 2257-2261
20. Li M.K., Garcia L., Patron N., et al. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function. BJU Int 101 (2008) 197-202
21. 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur J Pharmacol 288 (1995) 201-207
22. Hellstrom W.J., and Sikka S.C. Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. J Urol 176 (2006) 1529-1533
23. Seftel A., Rosen R., and Kuritzky L. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications. Int J Impot Res 19 (2007) 386-392